The Asia Pacific Hydrogel-based Drug Delivery System Market would witness market growth of 9.4% CAGR during the forecast period (2021-2027).
Drugs are combined with a hydrogel for local treatment of diseases in the buccal cavity like oral cancer, periodontal disease, fungal infection, and stomatitis. Hydrogel possesses properties like good adhesion and retention, which can use with oral cavity mucosa to attain local delivery of the drug. For that, a hydrogel-based drug delivery system is utilized in the distribution of drugs in the oral cavity. Vaginal, Transdermal, and Rectal are among the drug delivery route segments that are estimated to acquire a significant growth rate during the forecast period.
The huge customer base in the Asia Pacific region is attracting various players of the market to enter and proper the regional market. In addition, the growing focus of the pharma companies on R&D to improve the efficacy of their products and make other new medicinal products would create lucrative opportunities for market growth.
Moreover, the new trends of hydrogel-based drug delivery systems for the delivery of therapeutic components and diagnostics for various infectious diseases like malaria, acquired immune deficiency syndrome (AIDS), influenza, tuberculosis, and ebola. This would further lead to the increasing demand for the hydrogel-based drug delivery system in the Asia Pacific market.
The Synthetic market dominated the Malaysia Hydrogel-based Drug Delivery System Market by Polymer Origin in 2020, thereby, achieving a market value of $75.2 Million by 2027. The Natural market is estimated to grow at a CAGR of 11.1% during (2021 - 2027).
Based on Polymer Origin, the market is segmented into Synthetic, Natural and Hybrid. Based on Delivery Route, the market is segmented into Ocular, Subcutaneous, Oral Cavity, Topical and Other Delivery Routes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Hydrogel-based Drug System Market is Projected to reach USD 9.3 Billion by 2027, at a CAGR of 8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Inc., Medtronic PLC, Galderma S.A., Endo International PLC, Ferring Holdings SA, Akorn Operating Company LLC, Tolmar Pharmaceuticals, Inc., Blairex Laboratories, Inc., and Ocular Therapeutix, Inc.
By Polymer Origin
By Delivery Route
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
